Accelerating neurological treatments
from bench to bedside & beyond

Neureka is the only integrated digital biomarker platform for neurology that enables personalized interventions, spanning from clinical trials to ongoing patient support.

Built for care providers & the biopharmaceutical industry

We optimize value across customer segments

CARE PROVIDERS
Clinic
STREAMLINE
  • Reduce on-site staff needed for monitoring 
  • Real-time data-driven treatment
Remote
EXPAND
  • Scalable, comfortable at-home monitoring 
  • Unlock accurate long-term health data
BIOPHARMA & DEVICE COMPANIES
Clinical Trials
ACCELERATE
  • Reduce costs and accelerate trial speed with digitization
  • Enable adaptive trial design
Personalized Medicine
OPTIMIZE
  • Faster, safer medication titrations & adherence
  • Improve patient outcomes & engagement

How it works

We turn complex data into actionable insights in real-time
Neureka accelerates neurological treatments with unparalleled accuracy.

How it works

We turn complex data into actionable insights in real-time
Neureka accelerates neurological treatments with unparalleled accuracy.
Integrate
Device-agnostic biomarker & medication data collection from 3rd-party and Neureka-patented wearable & nearable devices.
Analyze
Our proprietary AI-driven technology seamlessly analyzes biometric data in real time with proprietary algorithms tailored to disease area and use cases.
Optimize
Neureka uses this analysis to deliver comprehensive insights for drug development, disease monitoring, and medication management.

Shown to improve quality of life

+

0

%

Quality of life

+

0

%

General health

+

0

%

Care partner engagement

+

0

%

Capacity to work

Backed by trusted organizations

About Neureka

We're here to radically transform neurology. Our goal is to improve treatment outcomes with more personalized care, from the research bench to any bedside—and beyond.

Neurology is slow and fragmented. Data is power in clinical trials and personalized care, but it is fragmented and hard to analyze for researchers, and overwhelming for patients to understand. That’s why we invented proprietary AI-driven technology to unify and interpret complex neurological data with unparalleled precision, delivering comprehensive insights, accelerating decision-making, while enhancing the accuracy and efficiency of clinical trials and patient care. 

Meet our team

We’re a passionate team of patient advocates, medical professionals, data analysts, and entrepreneurs—with deep expertise in digital health.

Working together, we're inspired to help improve the quality of life of people living with epilepsy.

Ray Iskander
Ray Iskander
CEO + Board Member
Serial Entrepreneur, Data Scientist, Co-founder, Mirametrix (acquired by NASDSAQ:LSCC Lattice Semiconductor) Co-founder, Thirdwayv, CA, USA
John Stern, MD
John Stern, MD
Chair of the Scientific Advisory Board
Professor Director, Epilepsy Clinical Program Director, Epilepsy Fellowship Program Co-Director, UCLA Seizure Disorder Center UCLA Department of Neurology
Vikram Rao, MD, PhD
Vikram Rao, MD, PhD
Member, Scientific Advisory Board
Vikram R. Rao, MD, PhD, FAES Ernest Gallo Distinguished Professor in Neurology Associate Professor of Clinical Neurology Chief, Epilepsy Division Department of Neurology and Weill Institute for Neurosciences University of California, San Francisco
Kramay Patel, PhD
Kramay Patel, PhD
Advisor
MD candidate PhD in Biomedical Engineering and Computational Neuroscience
Max Monahan-Ellison
Max Monahan-Ellison
Advisor, Corporate Strategy & Partnerships
Decade of experience in health & life sciences, board member of multiple health tech, research, and policy organizations
Dr. Nardin Samuel
Dr. Nardin Samuel
Chief Medical Officer
Co-Founder and CEO of Cove Neurosciences. Resident Physician and Post-Doctoral Research Fellow at the University of Toronto
Jörg Hölzing, PhD
Jörg Hölzing, PhD
Non-Executive Director
20+ years' healthcare experience; most recently SVP Strategy & Customer Solutions at Roche; Managing Director of mySugr GmbH
Lara Kidd
Lara Kidd
Head of Clinical Communications

Meet our team

We’re a passionate team of patient advocates, medical professionals, data analysts, and entrepreneurs—with deep expertise in digital health.

Working together, we're inspired to help improve the quality of life of people living with epilepsy.

Ray Iskander
Ray Iskander
CEO + Board Member
Serial Entrepreneur, Data Scientist, Co-founder, Mirametrix (acquired by NASDSAQ:LSCC Lattice Semiconductor) Co-founder, Thirdwayv, CA, USA
John Stern, MD
John Stern, MD
Chair of the Scientific Advisory Board
Professor Director, Epilepsy Clinical Program Director, Epilepsy Fellowship Program Co-Director, UCLA Seizure Disorder Center UCLA Department of Neurology
Vikram Rao, MD, PhD
Vikram Rao, MD, PhD
Member, Scientific Advisory Board
Vikram R. Rao, MD, PhD, FAES Ernest Gallo Distinguished Professor in Neurology Associate Professor of Clinical Neurology Chief, Epilepsy Division Department of Neurology and Weill Institute for Neurosciences University of California, San Francisco
Kramay Patel, PhD
Kramay Patel, PhD
Advisor
MD candidate PhD in Biomedical Engineering and Computational Neuroscience
Max Monahan-Ellison
Max Monahan-Ellison
Advisor, Corporate Strategy & Partnerships
Decade of experience in health & life sciences, board member of multiple health tech, research, and policy organizations
Dr. Nardin Samuel
Dr. Nardin Samuel
Chief Medical Officer
Co-Founder and CEO of Cove Neurosciences. Resident Physician and Post-Doctoral Research Fellow at the University of Toronto
Jörg Hölzing, PhD
Jörg Hölzing, PhD
Non-Executive Director
20+ years' healthcare experience; most recently SVP Strategy & Customer Solutions at Roche; Managing Director of mySugr GmbH
Lara Kidd
Lara Kidd
Head of Clinical Communications

Learn More

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.